| Poster Programme |
| P1 |
Study of keratinocyte response after exposure to sensitizers in a reconstructed human epidermis
A. Frankart, University of Namur (FUNDP), Namur/B; A. Coquette, SGS Life Science, Wavre/B; K.-R. Schroeder, Henkel, Düsseldorf/D; Y. Poumay, University of Namur (FUNDP), Namur/B |
| P2 |
EDI-Co Skin 3D-Co-culture model combined with RBM MAP analyses: Optimized examination of human immune cell function in skin product testing
G. M. Stein, EDI GmbH, Reutlingen/D; J. Mapes, J. Kemp, S. Küsters, Rules-Based Medicine Inc, Austin, TX/USA; M. Schmolz, EDI GmbH, Reutlingen/D |
| P3 |
Characterization of human reconstructed skin models for activities of xenobiotic metabolizing enzymes
K. Guth, C. Jäckh, A. Noss, V. Blatz, BASF SE, Ludwigshafen/D; K. Reisinger, Henkel AG & Co. KGaA, Düsseldorf/D; E. Fabian, B. van Ravenzwaay, R. Landsiedel, BASF SE, Ludwigshafen/D |
| P4 |
Expanding primary cells
F. Schuller, M. Butueva, H. Hauser, D. Wirth, Helmholtz Centre for Infection Research, Braunschweig/D; R. Schucht, InSCREENeX GmbH, Braunschweig/D; T. May, Helmholtz Centre for Infection Research, Braunschweig/D |
| P5 |
Analysis of xenobiotic metabolizing enzyme and interleukin expression and release for the prediction of in vitro skin irritation and/or sensitization
E.C.E. Novosel, M. Kaufmann, H. Walles, Fraunhofer IGB, Stuttgart/D |
| P6 |
In vitro development and characterization of canine epidermis in a porcine dermal acellular matrix
S. Cerrato, P. Brazís, Univet, Barcelona/E; A. Meana, Centro de Transfusiones del Principado de Asturias, Oviedo/E; D. Fondevila, A. Puigdemont, UAB, Barcelona/E |
| P7 |
Membranes made from collagen type I and methylcellulose for skin replacement
A. Walther, A. Lode, J. Meesane, T. Hanke, M. Gelinsky, Technische Universität Dresden/D |
| P9 |
Novel in vitro 3D skin model to simulate a Herpes simplex infection
I. Hogk, University of Stuttgart/D; M. Kaufmann, D. Finkelmeier, S. Rupp, H. Walles, A. Burger-Kentischer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart/D |
| P10 |
Construction of an immuno-competent skin model to investigate the allergenic potential of novel chemicals
D. Chau, University of Nottingham/UK; C. Johnson, S. MacNeil, J. Haycock, University of Sheffield/UK; A. Ghaemmaghami, University of Nottingham/UK |
| P11 |
Comparative studies on the metabolism of benzo[a]pyrene in keratinocytes, in vitro skin models and human skin ex vivo - metabolite patterns as indicator for the metabolic capacity of skin equivalents?
J. Brinkmann, C. Hutzler, S. Trappe, K. Stolpmann, BfR-Federal Institute for Risk Assessment, Berlin/D; U. Bock, Across Barriers GmbH, Saarbrücken/D; M. Liebsch, BfR-ZEBET, Center for Alternatives to Animal Testing, Berlin/D; F. Henkler, BfR-Federal Institute for Risk Assessment, Berlin/D; A. Luch, BfR-Federal Institute for Risk Assessment and ZEBET, Berlin/D |
| P12 |
Development of human inflammatory skin equivalents
E.H. van den Bogaard, M. Bergers, R.T. de Boer-van Huizen, E. van Rijssen, H.J. Koenen, I. Joosten, J. Schalkwijk, G.S. Tjabinga, Radboud University Nijmegen Medical Centre/NL |
| P13 |
Quantification of esterase activity in human keratinocytes and fibroblasts, ex vivo skin and reconstructed human skin models
F. Baetz, G. Weindl, M. Schäfer-Korting, Freie Universität Berlin/D |
| P14 |
Biotransformation of prednicarbate in reconstructed human skin models compared to excised human skin
W. Klipper, G. Weindl, M. Schäfer-Kortin, Freie Universität Berlin/D |
| P15 |
Cutaneous wound healing in the EpiDerm-FT full-thickness in vitro human skin model
H. Kandarova, MatTek Corporation, Ashland, MA/USA and MatTek In Vitro Life Science Laboratories, Bratislava/SK; P.J. Hayden, A.J. Armento, G. Stolper, C. Cooney, M. Li, M. Klausner, MatTek Corporation, Ashland, MA/USA |
| P16 |
Comparative investigation of photoxicity of chemical compounds by using the standard Balb 3T3 NRU phototoxicity test and a three-dimensional human skin model (EST 1000)
A. Heppenheimer, A. Poth, Harlan Cytotest Cell Research GmbH, Rossdorf/D; J. Hoffmann, H.W. Fuchs, CellSystems Biotechnologie Vertrieb GmbH, St. Katharinen/D |
| P17 |
Three-dimensional (3D) skin equivalents: a system for tissue reconstruction and a source of inspiration for anti-aging strategies
V. Cénizo, M. Dos Santos, N. Bechetoille, BASF Beauty Care Solutions France S.A.S., Lyon/F; O. Damour, Edouard Herriot Hospital, Lyon/F; V. André-Frei, BASF Beauty Care Solutions France S.A.S., Lyon/F |
|
